who-we-are

Clinical Trials

IAVI and its partners have conducted dozens of studies to advance the development of safe and effective AIDS vaccines. This database provides information on IAVI-supported clinical trials of preventive HIV vaccine candidates.

IAVI-Sponsored Studies

Study NamePhaseStatusStrategiesCandidatesCountriesVolunteersPartners
IAVI S001 I Ongoing Replicating Vector SeV-G(NP) United Kingdom
Kenya
Rwanda
65
Show Partners
IAVI A003 I Ongoing Vectored Immuno-prophylaxis rAAV1-PG9DP United Kingdom
24
Show Partners
IAVI 001 I Completed DNA DNA.HIVA United Kingdom
18
Show Partners
IAVI P002 I Completed DNA ; Viral Vector - Pox TBC-M4; ADVAX United Kingdom
32
Show Partners
IAVI 002 I Completed DNA DNA.HIVA Kenya
18
Show Partners
IAVI 010 IIa Completed DNA ; Viral Vector - Pox DNA.HIVA MVA.HIVA Kenya
United Kingdom
115
Show Partners
IAVI 011 I Completed Viral Vector - Pox MVA.HIVA South Africa
United Kingdom
Switzerland
81
Show Partners
IAVI A001 I Completed Viral Vector - Adeno-associated Virus tgAAC09 Belgium
Germany
India
80
Show Partners
IAVI A002 II Completed Viral Vector - Adeno-associated Virus tgAAC09 South Africa
Uganda
Zambia
91
Show Partners
IAVI C002 I Completed Viral Vector - Pox  ADMVA USA
48
Show Partners
IAVI C003 I Completed Viral Vector - Pox ADMVA USA
8
Show Partners
IAVI C004/DHO-614 I Completed DNA ADVAX USA
40
Show Partners
IAVI D001 I Completed Viral Vector - Pox TBC-M4 India
32
Show Partners
IAVI V001 I Completed DNA, Viral Vector - Pox VRC-HIVDNA016-00-VP,VRC-HIVADV014-00-VP Kenya
Rwanda
114
Show Partners
IAVI B001 I Completed Viral Vector - Adeno Ad35-GRIN, Ad35-GRIN/ENV USA
56
Show Partners
IAVI P001 I Completed DNA, Viral Vector - Pox ADVAX, TBC-M4 India
32
Show Partners
IAVI 016 I Completed Viral Vector - Pox ; DNA MVA.HIVA ; DNA.HIVA United Kingdom
24
Show Partners
IAVI 003 I Completed Viral Vector - Pox MVA.HIVA United Kingdom
8
Show Partners
IAVI 004 I Completed Viral Vector - Pox  MVA.HIVA Kenya
18
Show Partners
IAVI 005 I Completed Viral Vector - Pox; DNA MVA.HIVA; DNA.HIVA United Kingdom
9
Show Partners
IAVI 008 I Completed Viral Vector - Pox  MVA.HIVA Kenya
10
Show Partners
IAVI 009 I Completed DNA; Viral Vector - Pox  DNA.HIVA ; MVA.HIVA Uganda
50
Show Partners
IAVI C001 I Completed DNA  ADVAX USA
45
Show Partners
IAVI B003 I Completed Viral Vector - Adeno  Ad26.EnvA-01; Ad35-ENV USA
Kenya
Rwanda
South Africa
218
Show Partners
IAVI B002 I Completed Protein; Viral Vector - Adeno  Adjuvanted GSK investigational HIV vaccine formulation 1; Adjuvanted GSK investigational HIV vaccine formulation 2; Ad35-GRIN Kenya
Uganda
Zambia
147
Show Partners
IAVI B004 I Completed DNA, Viral Vector - Adeno HIV-MAG +GENEVAX® IL-12, Ad35-GRIN/ENV Kenya
Uganda
Rwanda
75
Show Partners
IAVI 006 I/II Completed DNA; Viral Vector - Pox  DNA.HIVA ; MVA.HIVA United Kingdom
120
Show Partners
IAVI V002 II Withdrawn DNA, Viral Vector - Adeno VRC-HIVDNA016 -00-VP, VRC-HIVADV014 -00-VP Kenya
Rwanda
Uganda
Zambia
0
 
PAVE 100 IIb Withdrawn DNA, Viral Vector - Adeno VRC-HIVDNA016 -00-VP, VRC-HIVADV014 -00-VP USA
0
 

Other IAVI-Supported Studies

Study NamePhaseStatusStrategiesCandidatesCountriesVolunteersPartners
X001

Imperial College London Sponsored

 I  Ongoing  Protein  CN54gp140  UK
 12
IAVI
N004 (HIVCORE 004)

University Oxford Sponsored

 I/IIa  Ongoing DNA; Viral Vector - Adeno; Viral Vector - Pox Ad35-GRIN; MVA.HIV-consv
pSG2.HIVconsv-DNA
 Kenya
72
IAVI
IDEA EV06

EuroVacc Foundation Sponsored

 I  Scheduled  DNA, Protein  DNA-HIV-PT123; AIDSVAX B/E

 

 Uganda
72 
 IAVI